DTC Updates from FDA’s Office of Prescription Drug Promotion: Standards… Thomas Sullivan Nov 15, 2024 0 In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the…
Medical Legal SCOTUS Rejects Chevron Deference Thomas Sullivan Oct 7, 2024 0 On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright…
Anti Kickback Policy and Medicine Compliance Update May 2023 Issue Features: Regulatory… Thomas Sullivan May 13, 2023 0 Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Compliance Policy and Medicine Compliance Update April 2023 Issue Features: DOJ’s… Thomas Sullivan Apr 15, 2023 0 Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
False Claims Act Policy and Medicine March 2022 Issue Features FDA Exclusivity, Baby Powder,… Thomas Sullivan Mar 25, 2023 0 Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
FDA REMS: FDA’s Application of Statutory Factors in Determining When a REMS Is… Thomas Sullivan Apr 22, 2019 0 Recently the FDA issued final guidance on FDA’s application of the statutory factors in determining when a risk evaluation and…
FDA FDA Social Media Guidance: Correcting Independent Third-Party… Thomas Sullivan Jun 18, 2014 0 The Food and Drug Administration (FDA) released two new guidances for drug and device companies looking to communicate…
FDA FDA Social Media Guidance: Presenting Risks and Benefits With Social… Thomas Sullivan Jun 18, 2014 0 The Food and Drug Administration (FDA) released two new guidances for drug and device companies looking to communicate…
FDA FDA Seeks Comments on Transparency and Communication for New Entities Thomas Sullivan Jul 23, 2012 0 The Food and Drug Administration (FDA) recently announced an opportunity for public comment on the statement of work for an…
Uncategorized The Food and Drug Administration Safety and Innovation Act (FDASIA):… Thomas Sullivan Jul 19, 2012 0 The Food and Drug Administration Safety and Innovation Act (FDASIA), signed into law on July 9, 2012, gives FDA the authority to…